ReviewCurrent medicinal chemistry2026

Pharmacological Targeting of NRF2 Represents a Promising Therapeutic Approach for Pyroptosis-Related Non-Alcoholic Fatty Liver Disease.

Yinggang Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.